ePrints@IIScePrints@IISc Home | About | Browse | Latest Additions | Advanced Search | Contact | Help

Expression analysis of microRNA-155 in type 2 diabetes in Kashmiri population

Majid, M and Masood, A and Masoodi, SR and Naykoo, NA and Shah, IA and Nissar, B and Khan, NS and ul Afshan, F and Ganai, BA (2020) Expression analysis of microRNA-155 in type 2 diabetes in Kashmiri population. In: International Journal of Diabetes in Developing Countries, 40 (4). pp. 518-524.

[img] PDF
INT_JOU_DIA_DEV_COU_2020.pdf - Published Version
Restricted to Registered users only

Download (435kB) | Request a copy
Official URL: https://dx.doi.org/10.1007/s13410-020-00840-5


Purpose: The present study aimed to evaluate the expression of microRNA-155 (miR-155) in type 2 diabetes mellitus (T2DM) and assess its correlation with clinicopathological characteristics of this type. Methods: MiR-155 expression was detected in 20 T2DM blood samples and 23 blood samples of healthy controls using fluorescent reverse transcription-quantitative polymerase chain reaction (RT-qPCR). The association between miR-155 expression and clinicopathological features was also analyzed. Result: We found higher values of quantitative parameters like blood pressure, blood sugar levels, and weight in cases compared to controls (p < 0.05). Among qualitative data we found that healthy patients were more physically active than T2DM patients (p < 0.05), while family history and smoking status were almost same in cases and controls. RT-qPCR results revealed that miR-155 expression levels were significantly decreased in T2DM cases (90). However, miR-155 expression was not significantly correlated with various clinicopathological parameters (p > 0.05). We evaluated miR-155 expression between males and females; however, we found no gender-specific difference in the expression. Patients exhibiting high miR-155 expression levels were observed to have short duration of T2DM than that of patients with reduced expression of miR-155; however, this difference was not statistically significant (p > 0.05). Conclusion: The current results demonstrated that miR-155 may be involved in resistance against T2DM and may be negatively associated with clinical parameters of T2DM patients. The study was limited by its observational study design, so additional studies involving pathophysiology are required to clarify the role of miR-155 in T2DM. © 2020, Research Society for Study of Diabetes in India.

Item Type: Journal Article
Publication: International Journal of Diabetes in Developing Countries
Publisher: Springer
Additional Information: copy right for this article belongs to Springer
Keywords: MicroRNA-155 . Type 2 diabetes . Reverse transcription-quantitative polymerase chain reaction
Department/Centre: Division of Biological Sciences > Molecular Reproduction, Development & Genetics
Date Deposited: 26 Nov 2020 09:46
Last Modified: 26 Nov 2020 09:46
URI: http://eprints.iisc.ac.in/id/eprint/65940

Actions (login required)

View Item View Item